Welcome to the detailed analysis for swixxbiopharma.com. This domain is officially recognized as About us | Swixx BioPharma | Modern Medicines for All. According to their official web presence, their primary focus is: "Detailed SEO and authority metrics for swixxbiopharma.com. Swixxbiopharma currently holds an estimated domain authority score of 71/100 in the .COM namespace based on our global index mapping.".
"Swixx BioPharma was created to replace biopharma, OTC and medical device multinationals’ subsidiaries in those countries, or therapeutic areas, that our partners choose not to enter, or to exit. Over the past decade, we have swiftly evolved into one of the largest, most professional and reliable partners in the countries of Central & Eastern Europe, Russia/Eurasia and Greece for international healthcare companies."
"Building on this foundation, Swixx has continued to expand. In September 2023, we entered the Middle East, followed by a strategic acquisition of Laboratorios Biopas SA in May 2024, that extended our reach to Latin America. Today, our group of companies offers comprehensive coverage across Central & Eastern Europe, MENAT, Latin America and CIS / Eurasia (Russia and Belarus operations were moved to Swixx Healthcare SA at the end of 2024)."
"At Swixx, we believe that every human being deserves access to the latest, evidence-based medical innovation. We are proud to have been selected by many of the world’s leading healthcare companies to bring their products to patients. Without our own R&D or manufacturing, we are fully dedicated to supporting our partners in bringing breakthrough treatments to patients and improving diagnoses. We share the values of our partners in healthcare and work to the same ethical and quality standards."
"Swixx’s extraordinary growth was recognized by the Financial Times (FT) in their “Europe’s fastest-growing companies” award. Based on a 70,6% CAGR, Swixx ranked 9th out of all European companies in the Health Care & Life Sciences sector in 2024 FT/Statista ranking. The  full 2024 FT 1000 report is available here: https://www.ft.com/ft1000-2024."
By comparing swixxbiopharma.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to swixxbiopharma.com.
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
As of September 30, 2026, swixxbiopharma.com holds an estimated domain authority score of 36/100 based on our VisitRank tracking algorithms.
You can find the best alternatives and similar sites to swixxbiopharma.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Common Misspellings & Typo Domains for swixxbiopharma.com: